Dec 27, 2016 by Brian Feroldi3 Best Stocks for RetireesThese three stocks offer investors value, growth, and yield, making them a great choice for retirees.
Dec 26, 2016 by Brian Feroldi, Keith Speights, Cory Renauer, and George Budwell, PhD4 Biotech Stocks to Buy in JanuaryOn the hunt for a biotech bargain as we head into the new year? If so, our team of healthcare experts think these four biotech stocks deserve a closer look.
Dec 24, 2016 by Brian Feroldi3 Great Income Stocks That Could Double Their DividendsThese three income stocks have plenty of room left to grow their dividends in the years ahead.
Dec 23, 2016 by Brian Feroldi3 Stocks You Can Keep ForeverThis Fool believes that The Priceline Group, Mercadolibre, and Proto Labs are ideal long-term holdings.
Dec 23, 2016 by Brian FeroldiTop Growth Dividend Stocks to Buy in 2017Are you looking for great stocks that offer both growth and income potential? If so, give FactSet Research Systems, Starbucks, and MarketAxess a closer look.
Dec 22, 2016 by Brian FeroldiThese Dividend Stocks Could Double in 2017Abercrombie & Fitch, Seaspan, and GNC Holdings have been horrific performers in 2016. Could better times lie ahead for these dividend-paying stocks?
Dec 20, 2016 by Brian FeroldiIllumina Has Dropped 32% in 2016 -- Is the Bottom Finally in Sight?It's been a rough year to be an investor in the genetic-testing equipment maker. Are we finally nearing bottom, or could there be more pain ahead?
Dec 20, 2016 by Brian FeroldiWhy ACADIA Pharmaceuticals Inc. Is Soaring TodayShares jump in response to the company reporting upbeat clinical data from an important Phase 2 trial.
Dec 19, 2016 by Brian FeroldiACADIA Pharmaceuticals Inc.'s Stock Has Fallen 27% in 2016 -- Have We Hit Bottom?It's been a rough year for investors in the commercial-stage biopharma, but here's why a turnaround could be in the cards.
Dec 19, 2016 by Brian Feroldi, Sean Williams, Dan Caplinger, Tyler Crowe, Daniel Miller, Matt DiLallo, and Steve Symington7 Top Stocks We're Excited About Headed Into 2017On the hunt for a few great stocks to buy as we head into the new year? Our team of experts thinks that these seven companies deserve a closer look.
Dec 19, 2016 by Brian FeroldiThese 3 Stocks Are Up Over 500% Over the Last 5 YearsIt's been a great half-decade to be an investor in these three stocks.
Dec 18, 2016 by Brian Feroldi3 Unbelievably Undervalued Dividend StocksBrookfield Property Partners, Ford, and Gamestop are currently trading for absurdly cheap prices.
Dec 18, 2016 by Brian FeroldiDoes Visa Pass Warren Buffett's Test?How does the payment processing giant stack up against Buffett's acquisition criteria?
Dec 16, 2016 by Brian FeroldiHere's Why TherapeuticsMD Inc. Is Soaring TodayShares jump in response to bullish new coverage by an analyst firm.
Dec 16, 2016 by Brian FeroldiWhere to Invest Money in 2017: 3 Great IdeasCVS Health, Paycom Software, and Illumina all look like great buys as we prepare for the year ahead.
Dec 15, 2016 by Brian FeroldiHere's Why Pacific Biosciences of California Is Collapsing TodayShares crater in response to the news that Roche has decided to terminate its partnership agreement with the company.
Dec 14, 2016 by Brian FeroldiWarren Buffett's Worst Stocks of 2017Even the Oracle of Omaha doesn't pick winners 100% of the time.
Dec 13, 2016 by Brian Feroldi3 Beaten-Up Cheap Stocks: Are They Bargains?These three companies are trading at discounted prices, but are they bargains or value traps?
Dec 13, 2016 by Brian FeroldiThese Growth Stocks Could Double in 2017The combination of fast growth and a depressed stock price could lead to big gains in 2017.
Dec 12, 2016 by Brian FeroldiHere's Why Ophthotech Corporation Is Being Obliterated TodayShares collapse after the company reports disappointing results from two phase 3 clinical trials.
